Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone Therapy

Published:2019-01 Issue:1 Volume:103 Page:84-91
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Berlin Alejandro,Murgic Jure,Hosni Ali,Pintilie Melania,Salcedo Adriana,Fraser Michael,Kamel-Reid Suzanne,Zhang Jingbin,Wang Qiqi,Ch'ng Carolyn,Deheshi Samineh,Davicioni Elai,van der Kwast Theodorus,Boutros Paul C.,Bristow Robert G.,Chua Melvin L.K.

Funder

Terry Fox Research Institute

Movember

Prostate Cancer Canada

Canadian Cancer Society

National Medical Research Council

Duke-NUS Oncology Academic Program Proton Research Fund

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference26 articles.

1. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

2. Synergistic action of image-guided radiotherapy and androgen deprivation therapy;Locke;Nat Rev Urol,2015

3. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial;Warde;Lancet,2011

4. Short androgen suppression and radiation dose escalation for intermediate- and high-risk localized prostate cancer: Results of EORTC Trial 22991;Bolla;J Clin Oncol,2016

5. A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy;Zumsteg;Eur Urol,2013

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy;Cancers;2024-08-19

2. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

3. Genomic classifiers and prognosis of localized prostate cancer: a systematic review;Prostate Cancer and Prostatic Diseases;2024-01-10

4. Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI;Cancers;2023-10-31

5. Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial;International Journal of Radiation Oncology*Biology*Physics;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3